| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/1990 | CA2001112A1 Method to improve survival of patients during sepsis by diet composition |
| 04/21/1990 | CA2001108A1 Drugs comprising a glycosylated interleukine-2 |
| 04/21/1990 | CA2001107A1 Process for the isolation of glycosylated interleukine-2 |
| 04/21/1990 | CA2001008A1 Cpf peptide compositions and uses |
| 04/20/1990 | CA2001094A1 Chemical compounds |
| 04/19/1990 | WO1990004176A1 THE RECEPTOR BINDING REGION OF EBVgp350 |
| 04/19/1990 | WO1990004076A1 Combination lock for blood identification system |
| 04/19/1990 | WO1990004030A1 Sequences of nucleotides coding for a protein having an ureasic activity |
| 04/19/1990 | WO1990004018A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 04/19/1990 | WO1990003985A1 A differentiation antigen, nda5, associated with amplification of differentiation of t and b lymphocytes |
| 04/19/1990 | WO1990003984A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| 04/19/1990 | WO1990003983A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/19/1990 | WO1990003982A1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 04/19/1990 | WO1990003981A1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
| 04/19/1990 | WO1990003980A1 Therapeutic peptides |
| 04/19/1990 | WO1990003810A1 Delayed release compositions for wound healing |
| 04/19/1990 | WO1990003801A1 Vasopermeability-enhancing conjugates |
| 04/19/1990 | WO1990003798A2 Targetting agents |
| 04/19/1990 | WO1990003797A1 Stabilized composition based on growth factors of the family fgf and on dextrane sulfate, and its applications |
| 04/19/1990 | WO1990003796A1 Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
| 04/19/1990 | WO1990003793A1 Compositions containing cyclosporins |
| 04/19/1990 | WO1990003788A1 Method of making a free-flowing spray-dried edible powder comprising an oil |
| 04/19/1990 | WO1990003784A1 Cyclodextrin-peptide complexes |
| 04/19/1990 | WO1990003735A1 Methods and systems for producing hiv antigens |
| 04/19/1990 | WO1990003733A1 Osteogenic factors |
| 04/19/1990 | DE3934010A1 Veterinary vitamin compsns. - contg. lysozyme and lipophilic vitamin(s) |
| 04/19/1990 | DE3834662A1 Chlorocyclohexenonylalanine derivative, a process for its preparation and its use as microbicide |
| 04/19/1990 | CA2000929A1 Heterocyclic peptide renin inhibitors |
| 04/18/1990 | EP0364344A2 Novel peptidase inhibitors |
| 04/18/1990 | EP0364266A2 NSAID and/or EGF for enhancing the healing of corneal endothelial wounds |
| 04/18/1990 | EP0364235A1 Physiologically active peptide composition for nasal administration |
| 04/18/1990 | EP0364096A2 Gene expression elements and the production of chimeric mouse-human antibodies |
| 04/18/1990 | EP0364094A2 Use of fatty acids in the treatment of myalgic encephalomyelitis |
| 04/18/1990 | EP0363879A2 Proteinaceous composition |
| 04/18/1990 | EP0363876A1 Pharmaceutical compositions comprising calcitonin for intra-nasal administration and a spray unit for the administration of the same |
| 04/18/1990 | EP0363712A2 Hybrid monoclonal antibodies, their production and use |
| 04/18/1990 | EP0363675A1 New derivatives of human/bovine basic fibroblast growth factor |
| 04/18/1990 | EP0363671A2 Use of ACE inhibitors against the formation of neo-intima after vascular infliction |
| 04/18/1990 | EP0363622A1 Polypeptides having a plasminogen activator activity, their production and use |
| 04/18/1990 | EP0363589A2 Somatostatin analogues |
| 04/18/1990 | EP0363400A1 Method and apparatus for preparing composite skin replacement. |
| 04/18/1990 | EP0363386A1 Method to prepare a composition for treatment of amyotrophic lateral sclerosis |
| 04/18/1990 | EP0106889B1 Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy |
| 04/18/1990 | CN1041366A Process for synthesising peptides having t cell inhibitive gene activity |
| 04/18/1990 | CA2000989A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
| 04/18/1990 | CA2000940A1 In vivo neurotrophic cytoprotective alcohols |
| 04/17/1990 | US4918164 Tumor immunotherapy using anti-idiotypic antibodies |
| 04/17/1990 | US4918163 Medical diagnosis; infection treatment |
| 04/17/1990 | US4918162 Identifiying neural or lung cancer in human patients |
| 04/17/1990 | US4918161 Low molecular weight pulmonary surfactant proteins |
| 04/17/1990 | US4918055 Method of stimulating melanocytes by topical application of analogs of alpha-MSH, and compositions for use in same |
| 04/17/1990 | US4918054 Antibiotics called `chloropolysporins B and C`, a process for their preparation, and their therapeutic and veterinary use |
| 04/17/1990 | US4918008 Enzymatic decomposition of whey proteins, lactalbumin lactoglobulin, lysozyme, lactoferrin or serum albumin; used as ointment, analgesics, antiflammatory |
| 04/17/1990 | US4917893 Prolonged release microcapsules |
| 04/17/1990 | US4917888 Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
| 04/17/1990 | US4917887 Viricides |
| 04/17/1990 | US4917685 Porous membrane confining active materials and stabilizers |
| 04/17/1990 | CA1267999A1 Nonapeptide and decapeptide analogs of lhrh, useful as lhrh agonist |
| 04/17/1990 | CA1267998A1 Synthesis of hpgrf (somatocrinin) in liquid phase and intermediate peptides |
| 04/17/1990 | CA1267997A1 Polypeptides and process for the production thereof |
| 04/17/1990 | CA1267996A1 Peptides which are active on the central nervous system and have an action on the cholinergic system |
| 04/17/1990 | CA1267995A1 Biologically active peptides structurally related to regions within growth hormones |
| 04/13/1990 | CA2000438A1 Multi-phase contraceptive preparation |
| 04/12/1990 | CA2000537A1 Method for enhancing healing of corneal endothelial wounds |
| 04/11/1990 | EP0363342A1 Novel somatotropins |
| 04/11/1990 | EP0363284A2 Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes |
| 04/11/1990 | EP0363083A2 Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease |
| 04/11/1990 | EP0363063A2 Sheep growth hormone |
| 04/11/1990 | EP0362999A2 Improved carcass quality |
| 04/11/1990 | EP0362915A2 Synthetic polypeptides immunochemically reactive with HIV-antibodies |
| 04/11/1990 | EP0362909A2 Synthetic polypeptides immunochemically reactive with HIV-antibodies |
| 04/11/1990 | EP0362578A1 Treatment of cancer in mammals by concurrent administration of 4-quinoline carboxylic acid derivatives and interleukin-2 |
| 04/11/1990 | EP0362531A1 A human rhinovirus receptor protein that inhibits virus infectivity |
| 04/11/1990 | EP0362526A2 The Alpha-subunit of the LFA-1 leukocyte adhesion receptor |
| 04/11/1990 | EP0362520A2 Antibiotic mersacidine, process for producing it and its use as a medicament |
| 04/11/1990 | EP0362371A1 Il-2 receptor-specific chimeric antibodies |
| 04/11/1990 | EP0362332A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/11/1990 | EP0362298A1 Novel polypeptide having gamma-interferon activity |
| 04/11/1990 | EP0362297A1 Hepatic blocking agents |
| 04/11/1990 | EP0362290A1 Cloning of mite allergens |
| 04/11/1990 | EP0362278A1 Autocrine motility factors in cancer diagnosis and management |
| 04/11/1990 | EP0362218A1 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS. |
| 04/11/1990 | EP0211022B1 Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses |
| 04/11/1990 | CN1041182A 抗生素ge2270 Antibiotics ge2270 |
| 04/11/1990 | CN1041181A Process for preparation of new derivatives of human/bovine basic fibroblast growth factor |
| 04/11/1990 | CN1041160A Stable bioactive somatotropins |
| 04/11/1990 | CN1041159A Pettide compounds |
| 04/11/1990 | CN1041158A Pentapeptides and process for preparing same |
| 04/11/1990 | CN1041157A Anticoagulant peptide alcohols |
| 04/11/1990 | CN1041107A Swine growth promotion |
| 04/10/1990 | US4916213 Treatment of bone, colon and ovarian cancers; kits |
| 04/10/1990 | US4916119 Immunostimulant tripeptides |
| 04/10/1990 | US4916118 Pharmaceutical administration systems containing chemotactic peptides |
| 04/10/1990 | US4916117 Bronchitis, emphysema, colitis |
| 04/10/1990 | US4916073 Complementary dna |
| 04/10/1990 | US4916071 Poly-kringle plasminogen activator |
| 04/10/1990 | US4916070 Fibrin-specific antibodies and method of screening for the antibodies |
| 04/10/1990 | US4916063 Fermentation of polyangium |
| 04/10/1990 | US4915945 Absorption of concomitant protein onto hydrophobic carrier |
| 04/10/1990 | US4915941 Gamma-interferon |